Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Onco > Biological basis of cancer therapy > Flashcards

Biological basis of cancer therapy Flashcards

1
Q

What are the four main anti-cancer modalities?

A

Radiotherapy
Chemotherapy
Surgery
Immunotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List the different types of cytotoxic chemotherapy.

A 
Alkylating agents 
Pseudoalkylating agents 
Antimetabolites 
Anthracyclines 
Vinca alkaloids and taxanes 
Topoisomerase inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the main types of targeted therapy for cancer?

A

Monoclonal antibodies

Small molecule inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the term used to describe chemotherapy that is given following surgery and Before surgery?

A

Following - Adjuvant

Before - Neoadjuvant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do alkylating agents work?

A

They add an alkyl group to the guanine residues in DNA
This causes cross-linking of the DNA strands and prevents DNA from uncoiling at replication
This then triggers apoptosis (via a DNA checkpoint pathway)
It encourages mis-pairing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Name four alkylating agents.

A

Chlorambucil
Cyclophosphamide
Dacarbazine
Temozolomide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do pseudoalkylating agents work?

A

They have the same mechanism as alkylating agents but use platinum instead of alkyl groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Name three pseudoalkylating agents.

A

Carboplatin
Cisplatin
Oxaliplatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some side effects of alkylating and pseudoalkylating agents?

A 
Alopecia (except carboplatin) 
Nephrotoxicity 
Neurotoxicity 
Ototoxicity (platins) 
Nausea, Vomiting, Diarrhoea, Immunosuppression, Tiredness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do anti-metabolites work?

A

They masquerade as purine or pyrimidines leading to inhibition of DNA replication and transcription
They can also be folate antagonists (dihydrofolate reductase inhibitors)
This blocks DNA replication and transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Give six examples of anti-metabolites.

A 
Methotrexate 
Capecitabine 
Gemcitabine 
5-fluorouracil 
6-mercaptopurine 
Fludarabine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

State some side effects of anti-metabolites.

A

Alopecia (not 5-fluorouracil or capecitabine)
Bone marrow suppression
Increased risk of neutropenic sepsis
Nausea, Vomiting, Mucositis, Diarrhoea, Fatigue
Palmar-plantar erythrodysesthesia (PPE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do anthracyclines work?

A

They intercalate into DNA or RNA sequences and inhibit transcription and replication
It also blocks DNA repair
They create DNA damaging and cell membrane damaging oxygen free radicals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Give two examples of anthracyclines.

A

Doxorubicin

Epirubicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

State some side effects of anthracyclines.

A 
Cardiac toxicity (probably due to the free radicals) 
Alopecia 
Neutropenia 
Nausea, Vomiting, Fatigue 
Red urine (doxorubicin –‘the red devil’)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do vinca alkaloids and taxanes work?

A

Vinca alkaloids inhibit assembly of microtubules
Taxanes inhibit disassembly of microtubules
This forces the cells into mitotic arrest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

State some side effects of vinca alkaloids and taxanes.

A

Nerve damage (peripheral neuropathy and autonomic neuropathy)
Hair loss
Nausea, Vomiting
Bone marrow suppression
Arthralgia (severe joint pain without swelling or signs of arthritis)
Allergy

18
Q

How do topoisomerase inhibitors work?

A

Topoisomerase is responsible for the unwinding of DNA and they induce temporary single and double strand breaks in the phosphodiester backbone
Topoisomerase inhibitors alter the binding of topoisomerase to DNA and allow permanent breaks in the DNA

19
Q

Give three examples of topoisomerase inhibitors.

A

Topotecan
Irinotecan
Etoposide

20
Q

State some side effects of topoisomerase inhibitors.

A

Irinotecan = acute cholinergic type syndrome (diarrhoea, abdominal cramps, diaphoresis – so they are given atropine)
Hair loss
Nausea, Vomiting, Fatigue
Bone marrow suppression

21
Q

What are the six hallmarks of cancer?

A 
Self-sufficient 
Pro-invasive and metastatic 
Insensitive to anti-growth signals 
Non-senescent 
Anti-apoptotic 
Pro-angiogenic
22
Q

What are the four hallmarks of cancer that have recently been added?

A

Dysregulated metabolism
Inflammation
Evades the immune system
Unstable DNA

23
Q

Give three examples of receptors that are over-expressed in cancer.

A

EGFR – over-expressed in many breast and colorectal cancers
HER2 – breast
PDGFR – glioma (brain)

24
Q

Give an example of a ligand that is over-expressed in some cancers.

A

VEGF – prostate, kidney and breast cancer

25
Q

Give two examples of constitutive (ligand independent) receptor activation in cancer.

A

EGFR – lung cancer

FGFR – head and neck cancers, myeloma

26
Q

What do common suffixes mean in relation to monoclonal antibodies?

A

momab - Derived from mouse antibodies
ximab - Chimeric antibody
zumab - Humanised antibody
mumab - Fully human antibody

27
Q

Describe the structure of humanised monoclonal antibodies.

A

Murine regions are interspersed within the with the light and heavy chains of the Fab portion

28
Q

Describe the structure of chimeric monoclonal antibodies.

A

The murine component of the variable region of the Fab section is maintained integrally

29
Q

What effect can monoclonal antibodies have on receptors and their activation?

A

They target the extracellular component of receptors and can prevent receptor dimerization, neutralise the ligand and cause internalisation of the receptor

NOTE: they also activate Fc-receptor-dependent phagocytosis or cytolysis induced complement-dependent cytotoxicity or antibody-dependent cellular cytotoxicity (ADCC)

30
Q

Give two examples of monoclonal antibodies used in oncology.

A

Bevacizumab (avastin) – binds and neutralises VEGF

Cetuximab – targets EGFR

31
Q

How do small molecule inhibitors work?

A

They bind to the kinase domain of tyrosine kinase receptors within the cytoplasm and block autophosphorylation and downstream signalling

32
Q

What was the first targeted treatment for cancer and how did it work?

A

Glivec (imatinib) – it is a small molecule inhibitor that targets the ATP binding region within the kinase domain of BCR-ABL1
This inhibits the kinase activity of ABL1

33
Q

Give four examples of small molecule inhibitors that inhibit receptors.

A

Erlotinib (EGFR)
Gefitinib (EGFR)
Lapatinib (EGFR/HER2)
Sorafenib (VEGFR)

34
Q

Give three examples of small molecule inhibitors that inhibit intracellular kinases.

A

Sorafenib (Raf kinase) – this is in addition to its anti-VEGFR effects
Dasatinib (Src kinase)
Torcinibs (mTOR inhibitors)

35
Q

State some advantages and disadvantages of monoclonal antibodies.

A 
Advantages: 
High target specificity 
Cause ADCC, complement-mediated cytotoxicity and apoptosis induction 
Can be radiolabelled 
Long half-life 
Good for haematological malignancies 
Disadvantages: 
Large and complex structure 
Less useful against bulky tumours 
Only useful against targets with extracellular domains 
Not useful for constitutively activated tumours 
Cause immunogenicity and allergy 
IV administration 
Expensive
36
Q

State some advantages and disadvantages of small molecule inhibitors.

A

Advantages:
Can target tyrosine kinases without an extracellular domain or which are constitutively activated
Pleiotropic targets (useful in heterogenic tumours/cross-talk)
Oral administration
Good tissue penetration
Cheap

Disadvantages:
Shorter half-life, more frequent administration
Pleiotropic targets (more unexpected toxicity)

37
Q

State some resistance mechanisms to targeted therapies.

A

Mutations in ATP binding domain
Intrinsic resistance
Intragenic mutations
Upregulation of downstream signalling pathways

38
Q

Explain how anti-sense oligonucleotides work.

A

These are short single-stranded DNA-like molecules
They bind to the complementary sequence on mRNA and hinder its translation
It then recruits RNase H to cleave the target mRNA
Mechanism: anti-sense oligonucleotides

39
Q

Name a successful B-Raf inhibitor.

A

Vemurafenib

NOTE: side effects include arthralgia, skin rash and photosensitivity

40
Q

Explain how the PD-1 receptor-PDL1 ligand system works.

A

PD-1 receptor is on the cell membrane
When the ligand (PDL-1) binds to the PD-1 receptor, the body’s T cells can no longer recognise tumours as foreign
So blocking the PD-1 receptor will stimulate the immune system

41
Q

Name a drug that inhibiting PD-1.

A

Nivolumab (anti-PD1 antibody)

Onco (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions